Miller Mary

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 99% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Miller Mary's trades of Acrivon Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-07 2026-10-05
S Sale
8,192 +22.7%
395.06
US$2,446,342 		8,192 +22.7% 395.06 US$2,446,342
2026-08-20 2026-08-18
S Sale
6,170 -27.0%
345.80
US$1,495,655 		6,170 -27.0% 345.80 US$1,495,655
2026-07-23 2026-07-21
S Sale
63,647 +39.4%
69.94
US$576,527 		63,647 +39.4% 69.94 US$576,527
2022-02-17 2022-02-16
S Sale
16,677 -10.7%
5.95
US$99,253 		16,677 -10.7% 5.95 US$99,253